Seer (SEER) Common Equity (2020 - 2026)
Seer (SEER) posted quarterly Common Equity of $241.5 million for Q1 2026, down 22.36% year-over-year from $311.0 million in Q1 2025, and down 6.88% quarter-over-quarter from $259.3 million in Q4 2025.
Seer (SEER) Common Equity (2020 - 2026) Analysis & Trends
Seer's Common Equity history runs 7 years deep, the most recent figure standing at $241.5 million for Q1 2026.
- In Q1 2026, Common Equity fell 22.36% year-over-year to $241.5 million; the TTM figure through Mar 2026 stood at $241.5 million (down 22.36% YoY), while the FY2025 annual figure was $259.3 million, down 20.84% from the prior year.
- Common Equity for Q1 2026 stood at $241.5 million, down from $259.3 million in the prior quarter.
- The five-year high for Common Equity was $486.5 million in Q1 2022, with the low at $241.5 million in Q1 2026.
- The 5-year median for Common Equity is $383.6 million (2024), against an average of $371.1 million.
- The sharpest annual moves came in 2022 and 2026: Common Equity decreased 9.2% in 2022, then fell 22.36% in 2026.
- Seer's Common Equity stood at $447.0 million in 2022, then decreased by 11.21% to $396.9 million in 2023, then declined by 17.47% to $327.6 million in 2024, then slipped by 20.84% to $259.3 million in 2025, then decreased by 6.88% to $241.5 million in 2026.
- Business Quant data shows SEER's Common Equity at $241.5 million in Q1 2026, $259.3 million in Q4 2025, and $271.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 225.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 225.68 Mn |
| Mar 31, 2026 | 241.48 Mn |
| Dec 31, 2025 | 259.31 Mn |
| Sep 30, 2025 | 271.81 Mn |
| Jun 30, 2025 | 288.29 Mn |
| Mar 31, 2025 | 311.01 Mn |
| Dec 31, 2024 | 327.57 Mn |
| Sep 30, 2024 | 344.73 Mn |
| Jun 30, 2024 | 364.70 Mn |
| Mar 31, 2024 | 383.56 Mn |
| Dec 31, 2023 | 396.90 Mn |
| Sep 30, 2023 | 405.68 Mn |
| Jun 30, 2023 | 418.12 Mn |
| Mar 31, 2023 | 432.99 Mn |
| Dec 31, 2022 | 446.99 Mn |
| Sep 30, 2022 | 457.77 Mn |
| Jun 30, 2022 | 472.04 Mn |
| Mar 31, 2022 | 486.46 Mn |
| Dec 31, 2021 | 502.92 Mn |
| Sep 30, 2021 | 515.20 Mn |